Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves-Reference-Cited by-同舟云学术

Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves

Published:2022-02-08 Issue:6 Volume:327 Page:583
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Maslo Caroline¹,Friedland Richard¹,Toubkin Mande¹,Laubscher Anchen¹,Akaloo Teshlin¹,Kama Boniswa¹

Affiliation:

1. Netcare Ltd South Africa, Johannesburg, South Africa

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2787776/jama_maslo_2021_ld_210090_1644261894.2798.pdf

Reference6 articles.

1. SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020-March 2021.;Kleynhans;Emerg Infect Dis,2021

2. New COVID-19 variant detected in South Africa. National Institute for Communicable Diseases (NICD). Accessed December 20, 2021. https://www.nicd.ac.za/new-covid-19-variant-detected-in-south-africa/

3. Classification of Omicron (B.1.1.529) SARS-CoV-2 variant of concern. Accessed December 20, 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

4. Update on Omicron. Accessed December 20, 2021. https://www.who.int/news/item/28-11-2021-update-on-omicron

5. Network for Genomic Surveillance in South Africa (NGS-SA). SARS-CoV-2 sequencing update. December 17, 2021. Accessed December 20, 2021. https://www.nicd.ac.za/wp-content/uploads/2021/12/Update-of-SA-sequencing-data-from-GISAID-17-Dec-21_Final.pdf

Cited by 425 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efecto de la variante Ómicron sobre la incidencia y la letalidad durante la 6.ª onda epidémica COVID-19 en España;Medicina de Familia. SEMERGEN;2024-03

2. The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant;Vaccines;2024-02-05

3. Clinical factors associated with viral shedding time of SARS-CoV-2 Omicron variant in Japan;Journal of Infection and Chemotherapy;2024-02

4. Clinical features and effectiveness of SARS-CoV-2 vaccine in children with omicron infection in a tertiary hospital during the Omicron wave in China, December 2022–January 2023;2024-02-01

5. Vaccination and the risk of post-acute sequelae after COVID-19 In the Omicron-predominant period;Clinical Microbiology and Infection;2024-02